Design and Rationale for a Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Trial of Oral Arimoclomol in Inclusion Body Myositis

AuthID
 P-017-N8S
7
Author(s)
Barohn, RJ
·
McDermott, MP
·
Sundgreen, C
·
Blaettler, T
·
Hanna, MG
·
Dimachkie, M
Tipo de Documento
Article
Year published
2024
Publicado
in RRNMF Neuromuscular Journal
Volume: 5, Número: 2
Indexing
Crossref®
Google Scholar®
Publication Identifiers
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Info
At this moment we don't have any links to full text documens.

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2025 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service